Please assess the completion status of the following clinical trial:

Trial Title: Optimal Management of Malignant Dysphagia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥18 years~* Confirmed esophageal/gastroesophageal (GEJ) cancer (Siewert Type I and Type II only) of any histology on biopsy~* Dysphagia score ≥2~* Stage IV cancer/Metastatic disease~Exclusion Criteria:~* Expected life expectancy \< 3 months~* Inability to undergo stent insertion~* Siewert Type III gastroesophageal cancer~* Esophageal-Airway fistula

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Self-expanding stent alone (Type: ACTIVE_COMPARATOR): All patients in Arm A will receive self-expanding stent alone
- Brachytherapy and Stent therapy (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).